|
|
|
|
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
  Our Products
Our Newly Approved Products
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Our goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. We apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
 06/11/2008 | Press Release JAZZ PHARMACEUTICALS FILES FORM S-3 REGISTRATION STATEMENTS 06/11/2008 | Press Release JAZZ PHARMACEUTICALS ANNOUNCES DEVELOPMENT TIMELINE UPDATES 06/02/2008 | Press Release JAZZ PHARMACEUTICALS, INC. COMPLETES ENROLLMENT IN FIRST OF TWO PHASE III CLINICAL TRIALS OF SODIUM OXYBATE TO TREAT FIBROMYALGIA 05/13/2008 | Press Release JAZZ PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS 05/09/2008 | Press Release JAZZ PHARMACEUTICALS TO PRESENT AT CITIGROUP HEALTHCARE FORUM 05/08/2008 | Press Release JAZZ PHARMACEUTICALS, INC. SECURES $75 MILLION COMMITTED EQUITY FINANCING FACILITY 05/07/2008 | Press Release JAZZ PHARMACEUTICALS, INC. TO ANNOUNCE FIRST QUARTER RESULTS ON MAY 13, 2008 04/23/2008 | Press Release JAZZ PHARMACEUTICALS TO PRESENT AT MORGAN STANLEY CONFERENCE 04/14/2008 | Press Release JAZZ PHARMACEUTICALS' LUVOX CR IS NOW AVAILABLE FOR PATIENTS WITH SOCIAL ANXIETY DISORDER (SAD) AND OBSESSIVE COMPULSIVE DISORDER (OCD) |
|
© 2008 Jazz Pharmaceuticals, Inc. : Privacy Policy & Terms of Use | |
|
About Us : Our Products : News & Meetings : Partnering : Investors : Careers : Contact Us : Site Map : Product Reimbursement Assistance | |
Download our March 13, 2008 Investor Day Presentation (93 pages)